| DAIICHI SANKYO SP. ADR 1 |
| USA |
| Gesundheit |
| US23381D1028 / A1JPH1 |
| D4S0 (Frankfurt) |
| FRA:D4S0, ETR:D4S0, D4S0:GR |
| - |
| https://www.daiichisankyo.. |
|
Daiichi Sankyo Co., Ltd. Sponsored ADR represents the American Depositary Receipt for Daiichi Sankyo, a prominent Japanese pharmaceutical company. Established in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Co., this company specializ..
>Volltext.. |
| 29212.48 Mio. EUR |
| 27881.07 Mio. EUR |
| 11873.06 Mio. EUR |
| 2237.67 Mio. EUR |
| 1761.15 Mio. EUR |
| 0.95 EUR |
| 1661.13 Mio. EUR |
| 2992.55 Mio. EUR |
| 713.12 Mio. EUR |
| 0.7 |
| 15.56% |
| 25.83% |
| 0.21 EUR |
| 2.12% |
| 1.85% |
| 30.09.25 - 0.21249352€ 31.03.25 - 0.17745584€ >weitere anzeigen... |
| - |
| DAIICHI SANKYO ADR, DAIICHI SANKYO |
| 05.04.26 |
|